glutathione kills triple negative cancer Targeting the redox-programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance GSTP1 Is a Driver of
GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Glutathione overproduction mediates lymphoma initiating cells survival and has a sex dependent effect on lymphomagenesis Cell Death & Disease Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





